These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19509481)

  • 1. High rate of misclassification of treatment failure based on WHO immunological criteria.
    Castelnuovo B; Kiragga A; Schaefer P; Kambugu A; Manabe Y
    AIDS; 2009 Jun; 23(10):1295-6; author reply 1296. PubMed ID: 19509481
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 3. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring treatment: at what cost?
    Cohen J
    Science; 2004 Jun; 304(5679):1936. PubMed ID: 15218140
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir.
    Gisslén M; Norkrans G; Svennerholm B; Hagberg L
    AIDS; 1998 Jan; 12(1):114-6. PubMed ID: 9456264
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategic approaches to antiretroviral treatment.
    Havlir DV
    Top HIV Med; 2003; 11(4):145-9. PubMed ID: 12876333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
    Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
    Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A chronic infection with long-term treatment].
    Grivois JP; Bricaire F
    Soins; 2004; (687):36-9. PubMed ID: 15384773
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral treatment in HIV infection.
    Raines CP
    Lippincotts Prim Care Pract; 2000; 4(1):83-100. PubMed ID: 11022522
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.
    Sungkanuparph S; Anekthananon T; Hiransuthikul N; Bowonwatanuwong C; Supparatpinyo K; Mootsikapun P; Chetchotisakd P; Kiertiburanakul S; Tansuphaswadikul S; Buppanharun W; Manosuthi W; Techasathit W; Ratanasuwan W; Tantisiriwat W; Suwanagool S; Leechawengwongs M; Ruxrungtham K;
    J Med Assoc Thai; 2008 Dec; 91(12):1925-35. PubMed ID: 19133532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
    Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K
    AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical benefit of interventions driven by therapeutic drug monitoring.
    Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
    HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study.
    Dray-Spira R; Spire B; Heard I; Lert F;
    AIDS; 2007 Jan; 21 Suppl 1():S5-12. PubMed ID: 17159588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality analysis of HIV-1 infected patients for prioritizing antiretroviral drug therapy.
    Pathipvanich P; Rojanawiwat A; Ariyoshi K; Miura T; Pumpradit W; Wongchoosie S; Yingseree P; Warachit P; Sawanpanyalert P
    J Med Assoc Thai; 2004 Aug; 87(8):951-4. PubMed ID: 15471301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV research overview: interview with David Ho, M.D. Interview by John S. James.
    Ho D
    AIDS Treat News; 1997 Nov; (No 282):1-6. PubMed ID: 11364903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
    Beck EJ; Vitoria M; Mandalia S; Crowley S; Gilks CF; Souteyrand Y
    AIDS; 2006 Jul; 20(11):1497-502. PubMed ID: 16847404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinician's perspective: when to start antiretroviral treatment and when to change therapy.
    Montaner JS; Lange JM
    J Biol Regul Homeost Agents; 1995; 9(3):114-8. PubMed ID: 8782020
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4 cell count-guided treatment interruption: be smart and wait for more evidence.
    Arduino R
    Clin Infect Dis; 2005 Mar; 40(5):735-7. PubMed ID: 15714421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.